PlainPharmaWatch

CMS Open Payments · Tool

Lucid Diagnostics Inc. vs Osteoremedies, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Osteoremedies, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,355, versus 1,539 for the other company. Its single largest recorded recipient represents 36.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Lucid Diagnostics Inc.
HHI 1,539 · top recipient 35.8%
Ranked #850 of 1,838 companies by HHI
Osteoremedies, LLC
HHI 2,355 · top recipient 36.1%
Ranked #679 of 1,838 companies by HHI

Payment Overview

Total Payments
$394.0K
% of Industry
0.0%
Transactions
1,642
Avg per Transaction
$239.92
Recipients
1,603
Avg per Recipient
$245.76
Payment Types
4
Top Payment Type
Consulting Fee
Company B

Osteoremedies, LLC

Total Payments
$396.8K
% of Industry
0.0%
Transactions
183
Avg per Transaction
$2.2K
Recipients
183
Avg per Recipient
$2.2K
Payment Types
3
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Lucid Diagnostics Inc. vs Osteoremedies, LLC - total reported payments in CMS Open Payments PY2024

Osteoremedies, LLC$396.8KLucid Diagnostics Inc.$394.0K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Lucid Diagnostics Inc.

Consulting Fee $148.2K

72.9%

Food and Beverage $42.6K

20.9%

Compensation for Services Other Than Consulting $7.5K

3.7%

Travel and Lodging $5.0K

2.5%

Osteoremedies, LLC

Royalty or License $359.7K

90.7%

Consulting Fee $24.9K

6.3%

Food and Beverage $12.2K

3.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Lucid Diagnostics Inc.

  1. 1

    ALFRED LUI

    $72,797.20 · 12 txns

  2. 2

    JESS SAVALA

    $22,502.42 · 10 txns

  3. 3

    SEPER DEZFOLI

    $17,419.33 · 22 txns

  4. 4

    RICHARD GOMEZ

    $9,186.49 · 2 txns

  5. 5

    SANFORD MARKOWITZ

    $7,075.00 · 5 txns

Osteoremedies, LLC

  1. 1

    Robert Meneghini

    $143,166.40 · 23 txns

  2. 2

    Bryan Springer

    $76,278.94 · 12 txns

  3. 3

    Scott Sporer

    $73,022.20 · 4 txns

  4. 4

    Stephen Incavo

    $72,783.85 · 4 txns

  5. 5

    James Browne

    $10,224.35 · 24 txns

Summary Comparison

Metric Lucid Diagnostics Inc. Osteoremedies, LLC
Total Payments $394.0K $396.8K
% of Industry Total 0.0% 0.0%
Transaction Count 1,642 183
Avg per Transaction $239.92 $2.2K
Recipient Count 1,603 183
Avg per Recipient $245.76 $2.2K
Payment Type Count 4 3
Top Payment Type Consulting Fee Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.